In a paper published last month, researchers at UT Southwestern Medical Center introduced lipid nanoparticles — hollow, fatty ...

Brain Defender Supplement launches to support memory, focus, and brain health with natural nootropics. Backed by science, now ...

Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

US researchers are developing an AI-powered microscope system that could make soil health testing faster, cheaper, and more ...

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

Bacteria can precisely adjust their membrane lipid compositions to control the biophysical properties of their membranes, which allows them to thrive in various physical environments. Here ...

Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the 'Company”), a late-stage clinical biopharmaceutical company focused on the ...

Cambridge-driven research has identified a novel target with therapeutic potential for metastatic eye melanoma — an ...

Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative ...

NEW YORK - It is with great pleasure that we announce that Ludwig Princeton's Vanha Nhat Pham, a postdoctoral researcher in the ...

“By uncovering specific genetic vulnerabilities like the CDS1 and CDS2 relationship, we’re opening the door to new therapies ...